Siemens Healthcare launched the ACUSON S3000*, its latest ultra-premium ultrasound platform, at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, USA. The new system includes advanced automated ultrasound fusion imaging** as well as multi-modality review capabilities** to provide additional clinical and spatial information in the analysis of complex pathology and/or when performing interventional procedures such as biopsies.
The ACUSON S3000*, Siemens’ latest ultra-premium ultrasound platform offers best-in-class image quality and ultrasound imaging capabilities, including advanced ultrasound fusion imaging* and multi-modality review*. Additionally, it features the most comprehensive suite of elastography applications in the industry. The system’s performance is supported by the new high-density (HD) 8C3 HD transducer*, specially designed for obstetrics and pediatric applications. * Works in Progress. Not commercially available.
In combination with their comprehensive suite of elastography applications, Siemens highlighted its new strain imaging application Virtual Touch tissue IQ** imaging, reinforcing the company’s role as a leader in strain elastography imaging. Also at RSNA 2011, Siemens introduced the latest addition to their family of high-density (HD) transducers: the 8C3 HD transducer* specially designed for obstetrics and pediatric applications.
The new ultra-premium ACUSON S3000 ultrasound system advances Siemens' pioneering ultrasound technologies with its proprietary eSie Fusion** imaging, which enables the automatic fusion of 3-D computed tomography (CT) volumes with real-time ultrasound via a single click. Current fusion techniques require time-consuming manual registration of CT or magnetic resonance (MR) images. They also require the patient to lie motionless throughout the entire exam to avoid elaborate manual realignments. The automatic, one-click advanced registration capabilities of the ACUSON S3000 system eliminate these limitations, reducing CT image registration to mere seconds, and profoundly simplifying manual registration techniques to enhance workflow during MR volume registration.
"Using the new eSie Fusion** imaging technology allows us to significantly speed up our workflow", said assistant professor Dr. Dirk-André Clevert, section chief of the Interdisciplinary Ultrasound Center at Munich University Hospital Grosshadern, Germany, and one of the first physicians to test eSie Fusion. "Previously, the success of interventions was generally monitored by follow-up CT examinations. However, due to the new ultrasound fusion solution it should be possible to reduce the number of follow-ups done with CT. The use of fusion provides us with improved clinical information – without additional radiation. This is a great advantage for both the patients and the healthcare provider." Fusion imaging can play an important role not only in diagnosis and follow-up, but also in image-guided interventions.
Increased Diagnostic Confidence Through Multi-Modality Review
In addition to fusion imaging, the ACUSON S3000* system features multi-modality review capabilities allowing CT and/or MR images to be imported into the ultrasound system for a rapid, easy side-by-side comparison. These capabilities provide an additional layer of information to further increase diagnostic confidence and confirm therapeutic decisions.
Stiffness Map and Quantification in One Image
Building on its vast experience in ultrasound elastography imaging, Siemens showcased the most comprehensive suite of elastography applications available in the industry. The latest application to confirm Siemens' leadership in this field is Virtual Touch tissue IQ**, which permits the simultaneous display of a color-coded tissue stiffness map and shear wave velocity measurements in one single image. This application allows immediate visual assessment of lesions and their stiffness characteristics, while at the same time providing simultaneous quantitative evaluation.
Since its introduction in 2005, manual-compression eSie Touch elasticity imaging has been complemented by push-pulse Virtual Touch tissue software applications***, Siemens' proprietary implementation of ARFI (Acoustic Radiation Force Impulse) imaging. Virtual Touch tissue imaging*** and eSie Touch elasticity imaging create a visual stiffness map (known as an elastogram) via tissue compression. Complementing these two technologies, Virtual Touch tissue quantification*** additionally measures the propagation speed of shear waves to offer the first and only quantitative assessment of increased tissue stiffness – a frequent sign of pathology.
HD Transducer Technology – More Accurate Information in Every Clinical Image
Siemens' most recent proprietary high-density (HD) ultrasound transducer technology ensures the best possible information for the creation of every clinical image. Unlike conventional ultrasound transducer technologies, HD technology employs high-density ultrasound elements that deliver greater signal fidelity improving image compounding and providing the basis for noise- and clutter-free images with a high degree of contrast resolution and clear tissue differentiation.
Siemens' new 8C3 HD* ultrasound probe was primarily designed for obstetric and pediatric applications, permitting high-resolution imaging in a wide range of exams. The transducer features a small footprint for improved surface contact and enhanced scanning performance. A 50 percent larger field-of-view enables the display of a full third-trimester fetal head, improving measurements and anatomic visualization. The range of ultrasound transducers enabled on the ACUSON S3000* system also includes the recently introduced 6C1 HD high-density ultrasound probe for radiology, gynecology and obstetrics, as well as the 18L6 HD probe for superb imaging in small parts, including the breast and thyroid.
Preparing for a Changing Healthcare Market
To further strengthen its innovative power and competitiveness, Siemens Healthcare recently launched Agenda 2013, a global initiative to prepare for the changing healthcare market. It defines four fields of action – innovation, competitiveness, regional footprint, and people development – with specific measures to be implemented over the next two years. As part of this new initiative, the Siemens Ultrasound Business Unit will further extend its innovative portfolio with products that demonstrate how ultrasound solutions help manage the cost pressures in healthcare without sacrificing excellence in patient care.
* 510 (k) pending. Not commercially available.
** Works in Progress.
*** Virtual Touch tissue imaging and Virtual Touch tissue quantification are not available in the United States.The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros.
The statements by Siemens' customers described herein are on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist, e.g., hospital size, case mix, level of IT adoption, there can be no guarantee that others will achieve the same results.
Reference Number: HCP201111012eContact
Marion Bludszuweit | Siemens Healthcare
Münster researchers make a fly’s heartbeat visible / Software automatically recognizes pulse
12.03.2018 | Westfälische Wilhelms-Universität Münster
3-D-written model to provide better understanding of cancer spread
05.03.2018 | Purdue University
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences